• Skip to Content
  • Skip to Sidebar
IU

Indiana University Indiana University IU

Innovate IndianaNews and information on how IU is driving innovation, entrepreneurship and economic development

IU researchers recognized as next generation life science leaders

Posted on August 26, 2022 by Kevin Fryling

A new recognition program from an initiative to advance life sciences in Indiana has honored six researchers, faculty members or other individuals affiliated with Indiana University as the “next generation of life sciences leaders.”

23PAIR Award logo

The individuals are the inaugural recipients of BioCrossroads’s 23 PAIR, or Promising Achievers in Innovation and Research, Awards. Each recipient was nominated by a senior member of the state’s life science innovation community, many also affiliated with IU.

The recipients are described as “the most valuable resource to Indiana’s life sciences sector — those who are innovating, discovering, developing and delivering critical pharmaceuticals and biotech products, medical devices, equipment, and diagnostics as well as researching and creating new protocols to accelerate getting life improving and lifesaving products to patients all over the world.”

The IU-affiliated recipients are:

Nathan Alves, an assistant professor and director of translational research in the IU School of Medicine’s Department of Emergency Medicine. He is also CEO and co-founder of Indiana Lysis Technologies LLC, a startup company seeking to develop new, safer treatments for life-threatening blood-clots using a nanoparticle-based drug delivery platform developed by Alves, who holds seven U.S. patents. He was nominated by Gregory Coy, a partner at Taft Stettinius and Hollister, LLP, who served as one of Alves’ mentors through the BioCrossroads’ AXIS mentoring program.

Joseph Chabenne, an associate research professor in the IU Bloomington College of Arts and Sciences’ Department of Chemistry. Chabenne’s research focuses on an innovative approach to insulin-dependent diabetes treatment. He was nominated by Richard DiMarchi, IU Distinguished Professor and Linda and Jack Gill Chair in Biomolecular Science, in whose lab he earned a Ph.D. A former group vice president at Eli Lilly and Co., DiMarchi is known for his discovery and development of rDNA-derived Humalog® (LisPro-human insulin).

Erica Clinkenbeard, an assistant professor of medical and molecular genetics. Her research focuses on bone health and chronic kidney disease. Clinkenbeard was nominated by Ed Greenfield, a professor of orthopaedic surgery at the IU School of Medicine whose research investigate the use of FDA-approved drugs to block growth of lung cancers. Greenfield said Clinkenbeard’s research “could result in novel therapies for life-threatening conditions.”

Daniel Sheik, director of research at Amplified Sciences, a biotechnology company seeking to improve the treatment and detection of diseases such as pancreatic cancer based upon the research of Vincent Jo Davisson, a graduate of IU. A part of the IU Ventures portfolio, Amplified Biosciences has received investment from both the IU Philanthropic Fund and IU Angel Network. Sheik was nominated by Diana Caldwell, CEO of Amplified Sciences.

Travis Johnson, an assistant professor of biostatistics and health data science. Johnson’s research focuses on applying artificial intelligence and deep learning to understanding tumor and immune cell interactions, resulting in the identification of new biomarkers and therapeutic targets. He was nominated by Kun Huang, a professor and chair of biostatistics and health data science at the IU School of Medicine.

Ying Wang, an assistant professor of anesthesia at the IU School of Medicine. Her research advances the use integrative pain management with acupuncture to treat chronic pain associated with sickle cell disease and is supported in part by the NIH’s National Center for Complementary and Integrative Health. Wang was nominated by Fletcher White, the Vergil K. Stoelting Professor of Anesthesia at the IU School of Medicine.

Alves accepts a 23PAIR Award
Nathan Alves accepts a 23PAIR Award during a recognition event at The AMP at 16 Tech. Image courtesy Nathan Alves.

“Just as 23 pairs of chromosomes are the building blocks for the human body, Indiana’s life sciences sector is a critical and foundational component of the state’s economy,” said Lori LeRoy, executive vice president of communications for BioCrossroads.

“Indiana’s life sciences industry is fundamentally based on talent. We have some truly innovative early-in-career people who are doing groundbreaking work here that deserves to be put in the spotlight.”

A total of 23 individuals were named 23 PAIR awardees. The recipients were celebrated Aug. 23 during a recognition event at The AMP at 16 Tech in Indianapolis.

All winners and their nominators will also maintain engagement with BioCrossroads through activities and events, including coaching as “life sciences ambassadors.”

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Filed under: Entrepreneurship, IU Innovation and Commercialization Office, Research, Technology Commercialization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Innovate Indiana Button

Search Innovate Indiana

About Innovate Indiana

Join us as we highlight how IU innovation is accelerating economic growth in Indiana and beyond and creating a culture of entrepreneurship across the Hoosier state.

Innovate Indiana is maintained by the Indiana University Office of the Vice President for University Relations.

Recent Posts

  • Moving IU innovation to market to improve Hoosier health March 22, 2023
  • IU School of Medicine researcher develops a novel, highly efficient method of producing retinal organoids March 14, 2023
  • Strengthening civics education in Indiana and beyond March 10, 2023
  • Hoosier hoops great Alan Henderson set to bring his new venture game back to Bloomington March 8, 2023
  • IU School of Medicine researcher develops non-invasive tool to detect mutations that could potentially lead to breast cancer February 24, 2023

Categories

Bookmarks

  • Innovate Indiana website
  • IU Center on Representative Government
  • IU Impact
  • IU Innovation and Commercialization Office
  • IU Office of the Vice President for Research
  • IU Office of the Vice President for University Relations
  • IU Ventures

Subscribe to the Innovate Indiana blog

Opt out at any time.

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.